TRICLADROG

TRICLADROG is a fasciolicide antiparasitic product belonging to the benzimidazoles of action on immature, juvenile and adult stages of hepatic fasciola. It inhibits the synthesis of microtubules, through the union of triclabendazole with tubulin, causing a fatal alteration of the parasite, avoiding the uptake and utilization of glucose, the main energy substrate for the development of parasite stages.